BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

612 related articles for article (PubMed ID: 11238621)

  • 21. Expression of dual TCR on DO11.10 T cells allows for ovalbumin-induced oral tolerance to prevent T cell-mediated colitis directed against unrelated enteric bacterial antigens.
    Zhou P; Borojevic R; Streutker C; Snider D; Liang H; Croitoru K
    J Immunol; 2004 Feb; 172(3):1515-23. PubMed ID: 14734729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tolerance induction by anti-CD2 plus anti-CD3 monoclonal antibodies: evidence for an IL-4 requirement.
    Punch JD; Tono T; Qin L; Bishop DK; Bromberg JS
    J Immunol; 1998 Aug; 161(3):1156-62. PubMed ID: 9686574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytokines affecting CD4
    Hall BM; Plain KM; Tran GT; Verma ND; Robinson CM; Nomura M; Boyd R; Hodgkinson SJ
    Transpl Immunol; 2017 Aug; 43-44():33-41. PubMed ID: 28652007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD25+ immunoregulatory CD4 T cells mediate acquired central transplantation tolerance.
    Trani J; Moore DJ; Jarrett BP; Markmann JW; Lee MK; Singer A; Lian MM; Tran B; Caton AJ; Markmann JF
    J Immunol; 2003 Jan; 170(1):279-86. PubMed ID: 12496410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro expanded alloantigen-specific CD4+CD25+ regulatory T cell treatment for the induction of donor-specific transplantation tolerance.
    Jiang S; Golshayan D; Tsang J; Lombardi G; Lechler RI
    Int Immunopharmacol; 2006 Dec; 6(13-14):1879-82. PubMed ID: 17161340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD4+CD25+ T cells alloactivated ex vivo by IL-2 or IL-4 become potent alloantigen-specific inhibitors of rejection with different phenotypes, suggesting separate pathways of activation by Th1 and Th2 responses.
    Verma ND; Plain KM; Nomura M; Tran GT; Robinson C; Boyd R; Hodgkinson SJ; Hall BM
    Blood; 2009 Jan; 113(2):479-87. PubMed ID: 18827184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of foxP3+ regulatory T cells in the periphery of T cell receptor transgenic mice tolerized to transplants.
    Cobbold SP; Castejon R; Adams E; Zelenika D; Graca L; Humm S; Waldmann H
    J Immunol; 2004 May; 172(10):6003-10. PubMed ID: 15128783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alloantigen specific T regulatory cells in transplant tolerance.
    Hall BM; Tran G; Hodgkinson SJ
    Int Immunopharmacol; 2009 May; 9(5):570-4. PubMed ID: 19539571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD25+CD4+ regulatory T cells generated by exposure to a model protein antigen prevent allograft rejection: antigen-specific reactivation in vivo is critical for bystander regulation.
    Karim M; Feng G; Wood KJ; Bushell AR
    Blood; 2005 Jun; 105(12):4871-7. PubMed ID: 15713793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Helper T lymphocyte unresponsiveness to cardiac allografts following transient depletion of CD4-positive cells. Implications for cellular and humoral responses.
    Bishop DK; Li W; Chan SY; Ensley RD; Shelby J; Eichwald EJ
    Transplantation; 1994 Sep; 58(5):576-84. PubMed ID: 7522364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The early IL-4 response to Leishmania major and the resulting Th2 cell maturation steering progressive disease in BALB/c mice are subject to the control of regulatory CD4+CD25+ T cells.
    Aseffa A; Gumy A; Launois P; MacDonald HR; Louis JA; Tacchini-Cottier F
    J Immunol; 2002 Sep; 169(6):3232-41. PubMed ID: 12218142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparative study between T regulatory type 1 and CD4+CD25+ T cells in the control of inflammation.
    Foussat A; Cottrez F; Brun V; Fournier N; Breittmayer JP; Groux H
    J Immunol; 2003 Nov; 171(10):5018-26. PubMed ID: 14607898
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of alloreactive CD8+ T cells operates via CD4-dependent and CD4-independent mechanisms and is CD154 blockade sensitive.
    Zhai Y; Meng L; Busuttil RW; Sayegh MH; Kupiec-Weglinski JW
    J Immunol; 2003 Mar; 170(6):3024-8. PubMed ID: 12626556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD4+CD25high regulatory cells in human peripheral blood.
    Baecher-Allan C; Brown JA; Freeman GJ; Hafler DA
    J Immunol; 2001 Aug; 167(3):1245-53. PubMed ID: 11466340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity.
    Powrie F; Correa-Oliveira R; Mauze S; Coffman RL
    J Exp Med; 1994 Feb; 179(2):589-600. PubMed ID: 7905019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abrogation of antibody-mediated allograft rejection by regulatory CD4 T cells with indirect allospecificity.
    Callaghan CJ; Rouhani FJ; Negus MC; Curry AJ; Bolton EM; Bradley JA; Pettigrew GJ
    J Immunol; 2007 Feb; 178(4):2221-8. PubMed ID: 17277127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tracking the immunoregulatory mechanisms active during allograft tolerance.
    Sánchez-Fueyo A; Weber M; Domenig C; Strom TB; Zheng XX
    J Immunol; 2002 Mar; 168(5):2274-81. PubMed ID: 11859115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD4+CD25- T cells that express latency-associated peptide on the surface suppress CD4+CD45RBhigh-induced colitis by a TGF-beta-dependent mechanism.
    Oida T; Zhang X; Goto M; Hachimura S; Totsuka M; Kaminogawa S; Weiner HL
    J Immunol; 2003 Mar; 170(5):2516-22. PubMed ID: 12594277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alloantigen-specific CD4(+) regulatory T cells induced in vivo by ultraviolet irradiation after alloantigen immunization require interleukin-10 for their induction and activation, and flexibly mediate bystander immunosuppression of allograft rejection.
    Hori T; Kuribayashi K; Saito K; Wang L; Torii M; Uemoto S; Kato T
    Transpl Immunol; 2015 Jun; 32(3):156-63. PubMed ID: 25861842
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The cellular basis of cardiac allograft rejection. IX. Ratio of naïve CD4+CD25+ T cells/CD4+CD25- T cells determines rejection or tolerance.
    Nomura M; Plain KM; Verma N; Robinson C; Boyd R; Hodgkinson SJ; Hall BM
    Transpl Immunol; 2006 Apr; 15(4):311-8. PubMed ID: 16635754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.